RightRep EN · PT Open the app
BLOG

Can You Train With Pelvic Organ Prolapse? The Heaviness-Door Audit: The Door Where the Symptom Is a Bulge You Can Feel and the Internet Hands You Either the Never-Lift-Again Script or the Kegels-Fix-Everything Script, Written for the Reader Who Trains, Has Been Told Something Is Descending, and Wants to Know Whether the Barbell Caused It or Whether It Belongs in the Program — Where the Census Column Puts Symptomatic Prolapse at 3–6% of Women Against Up to 50% Carrying Some Degree on Exam and the Cochrane's Own 50% of Parous Women, Where Swift's 497-Woman Population Curve Reads Stage 0 at 6.4% and Stage II at 47.7% — the Bell Curve Most Exam Rooms Never Explain — Where the Fear Column Meets Its Largest Instrument (the UK Biobank Accelerometer File: 47,674 Women, 8 Years, 779 Incident Cases, Moderate and Vigorous Activity Carrying No Association With Incident Prolapse) and the CrossFit File Puts Lifters and Matched Non-Lifters at 38.9% vs 44.4% on POP-Q With Identical Floor Strength, Where the Honest Dose Column Lives in the Runner Census (23% Symptomatic In-Session, OR 1.03 per Weekly Kilometer, Cesarean Protective at OR 0.42) and the Scoping Review's Transient Post-Session Descent, and Where the Treatment Column Is a Real Randomized File — POPPY: 447 Randomized, Symptoms −3.77 vs −2.09 at Twelve Months; the Cochrane's +17% Improvement-in-Stage Odds; PESSRI's Ring-and-Gellhorn Equivalence; the Postpartum Prevention Leg at OR 0.44

By RightRep AI Assistant · · 18 min read

Pelvic organ prolapse is the file where the internet's two default scripts — never lift again, you'll push it out and it's just kegels, carry on — both fail the reader at the exact door she walked in through, because this reader's symptom is specific: a heaviness, a pressure, a bulge she can feel — worse standing, worse at the end of the day, better lying down — and what she needs to know is whether the barbell caused it, whether it will get worse under load, and what the program does now. The never-lift script dies on the biggest instrument this fear has ever been handed: the UK Biobank accelerometer file — 47,674 women, eight years of follow-up, 779 incident prolapse cases — found no association between moderate or vigorous physical activity and developing prolapse [8], while the CrossFit comparison put lifters and matched non-lifters at 38.9% vs 44.4% on exam with identical pelvic-floor strength [9]. The kegels-carry-on script dies on the same file's honest legs: symptoms track in-session load — 23% of female road runners symptomatic while running, odds rising 3% per weekly kilometer [10] — transient descent follows single strenuous sessions [7], and unsupervised squeeze-counting is not the program the randomized column actually tested [1][2]. So the fences come first. First: the red-flag column — inability to empty the bladder, a bulge that will not reduce, bleeding or ulceration, or new severe pelvic pain — is same-day medical care, not a programming question. Second: this file assumes a clinician's exam — prolapse is staged (POP-Q, 0 through IV), and the stage-plus-symptom pair is what routes the program; a self-diagnosis off a mirror checklist is not the instrument [4]. Third: the postpartum reader takes the six-week clearance calendar first — the after-giving-birth door owns that return, and this file owns what it loads. Fourth: the post-surgical reader follows her surgeon's calendar, not this one. With the fences standing, the evidence underneath is unusually kind to training — at this door, exercise is not the risk column; it is the treatment column [1][2], the prevention column [3], and the fear column's biggest negative result [8][9].

The short answer: yes — training is the treatment column, not the risk column

Strip the file to its spine. The census reads two ways and the gap is the whole frame: symptomatic prolapse runs at 3–6% of women, while up to 50% carry some degree of descent on exam [4] — the Cochrane review opens with the same number, some degree of prolapse is seen in 50% of parous women [2]. Swift's population curve made it concrete: of 497 women examined for routine care, stage 0 support in 6.4%, stage I in 43.3%, stage II in 47.7%, stage III in 2.6%, stage IV in none [6] — a bell curve centered exactly on "some descent, no disease." The fear column has met its largest instrument and lost: 47,674 UK Biobank women with objectively measured activity, eight years of follow-up — no association between moderate or vigorous activity and incident prolapse [8]. The athlete files agree: symptomatic prolapse across sports runs 0–23% with parity the only consistent correlate [7], and CrossFit practitioners read statistically identical to matched high-intensity non-lifters [9]. The treatment column is a real randomized file: POPPY randomized 447 women with symptomatic stage I–III prolapse to individualized pelvic-floor muscle training or an advice leaflet — symptom scores fell 3.77 vs 2.09 points, adjusted difference 1.52 (95% CI 0.46–2.59, p=0.0053) at twelve months [1] — with the Cochrane pooling a 17% better chance of improvement in prolapse stage [2] and the postpartum meta-analysis pricing floor training at 56% lower odds of prolapse (OR 0.44) [3]. The device column works beside the training: PESSRI's ring and Gellhorn pessaries both significantly improved symptoms and neither beat the other [11]. That is the audit in one paragraph: this reader needs the census read correctly (a finding is not a verdict [4][6]), the dose managed in-session [7][10], and a floor trained like the muscle it is — which is not a limitation on the program; it is a muscle group added to it [1][2].

What prolapse actually is: a support system measured in stages, not a disease binary

The mechanics in a paragraph: the pelvic floor is a muscular diaphragm slung with ligaments and fascia, holding three compartments — bladder in front, uterus or vault in the middle, rectum behind — and prolapse is the descent of any of them toward the vaginal opening, staged by the POP-Q system from 0 (no descent) through IV (everted), with the hymen as the hinge where "finding" becomes "symptom" [4][6]. That hinge explains the entire symptom signature this door exists for: heaviness and bulge that build with hours upright and unload lying down [4]; dragging worsened by lifting days in the dose column's runners [10]; and the exam-room moment the file has to defuse — your exam found prolapse — which, read against Swift's curve, describes the median parous woman, not a diagnosis of anything [6]. Stage I is nearly universal territory, stage II sits at the hinge, and symptoms — not the stage number — are what the treatment column treats: POPPY enrolled stage I–III symptomatic women precisely because anatomy alone does not predict bother [1][4]. The reader who left an exam terrified by a stage number needs the bell curve drawn for her: 91% of Swift's routine-care population carried stage I or II [6], and the question that matters clinically is whether it talks [4].

The epidemiology column: the census nobody explains

How common is this door, really? The headline numbers from three directions. By symptoms: 3–6% of women — the figure that matters for planning services and programs [4]. By exam: up to 50%, and half of parous women — the figure that explains why "I was told I have a prolapse" is so often a description of the median pelvis [2][4]. By surgery: prolapse operations are performed twice as commonly as continence surgery, 6–18% of women across registries, at 1.5–1.8 per 1,000 women-years, peaking between 60 and 69 [4]. The forecast column says the waiting room is growing: US women with symptomatic pelvic floor disorders rise from 28.1 million (2010) to a projected 43.8 million by 2050, prolapse specifically from 3.3 to 4.9 million (+46%) [5]. And the risk-factor column indicts birth history and age, not the gym: in the Brazilian census of 432 women, vaginal delivery carried OR 6.68 (95% CI 4.16–10.73), a birth weight over 4 kg OR 2.06, menopause OR 2.79 — with 52.3% of the sample carrying some stage on exam [12]. The gym translation of that column is the quiet heart of this file: the strongest prolapse risk factors in the literature are how you were born into and how long you have lived — variables no barbell touches [4][12]. Which is precisely the question the next column tests directly.

The fear column: does training cause prolapse? The largest file says no

This is the section that separates this door from the way the internet tells it, and the reader deserves the strongest instrument stated plainly. The UK Biobank accelerometer cohort is the best-designed test the lifting-causes-prolapse fear has ever faced: 47,674 women aged 43–78 without prolapse, activity measured objectively on wrist accelerometers for a week (not recalled from a questionnaire), followed a median of eight years, 779 incident cases — and moderate-to-vigorous activity carried no association with developing prolapse [8]. The associations that did appear run opposite to gym folklore: each additional hour of light activity linked to 18% higher risk (light, cumulative upright time — not exercise), each hour of sedentary time to 5% lower risk, and swapping 30 minutes of light activity for moderate work cut risk 17% [8]. The one honest caution inside the file: women with a prior hysterectomy who did more vigorous activity ran 53% higher risk per additional 15 minutes a day [8] — a post-surgical routing flag, not a general one. The sport files stack on top: the scoping review of strenuous exercise and prolapse found symptomatic prevalence across athletes from 0% to 23% — Olympic weightlifters and powerlifters at the top of the range, parity the only factor associated in most studies [7] — and the CrossFit study put 18 lifters against 18 matched high-intensity non-lifters: 38.9% vs 44.4% on POP-Q (p=0.73), identical maximum contraction and endurance [9]. Read the column whole: barbell populations do not develop more prolapse than matched controls, objectively-measured exercise does not predict incident prolapse, and the model where load pushes organs out is not how these files read [7][8][9]. What load does move — measurably, reversibly — is the next column.

The dose column, printed honestly: symptoms track in-session load

The honest legs of this file matter as much as the headline, because this reader's symptom is load-responsive and she knows it. The runner census: 301 women recruited at road-running events, mean age 37, mean 28.6 km/week — 23% reported prolapse symptoms during running, with symptoms predicted by weekly distance (OR 1.03 per kilometer, 95% CI 1.01–1.05) and additional training sessions (OR 1.53), while cesarean delivery was protective (OR 0.42) [10]. The acute files: three studies in the scoping review measured the pelvic floor around single exercise sessions and found increased vaginal descent or symptoms immediately after strenuous work — transient, session-scoped findings [7], including one prospective cohort that developed prolapse findings after six weeks of military parachute training [7]. The honest null inside the treatment column: the scoping review even flags one randomized trial where transverse-abdominal training increased prolapse symptoms — a reminder that "core work" is not automatically floor-friendly when it is all pressure and no coordination [7]. How the three legs compose into one rule: symptoms in this door are a dose meter, not a verdict — they rise with session volume, they settle when the session ends [7][10], and the program variable they price is the size and shape of the load, not the existence of the program [8][10]. The practical shape of "smaller in-session dose": exhale on the effort instead of bearing down (the breath-holding door owns the pressure mechanics), prefer positions that own intra-abdominal pressure — supported, elevated, feet-not-flat-on-heavy-hinge days — and ramp impact and hinge volume on the same beginner ladder every other rehab door in this library uses [7][10].

The treatment column: the floor is the first prescription

The treatment question this reader actually asks — is there anything besides surgery? — has a randomized answer, and it is training. POPPY randomized 447 women with newly diagnosed symptomatic stage I–III prolapse across 25 centers to individualized one-to-one pelvic-floor muscle training or a prolapse lifestyle-advice leaflet: at twelve months, the training group's prolapse symptom score fell 3.77 points against 2.09 in controls — adjusted difference 1.52 (95% CI 0.46–2.59, p=0.0053), with adverse events judged unrelated to the training [1]. The shape of the winning program matters: not squeeze-counting from a leaflet — one-to-one, individualized, supervised, progressive — the trial's own delivery design, described physiotherapist-led from diagnosis onward [1]. The Cochrane floor beneath it: four trials pooling 857 women, every trial measuring symptoms favoring the training group, and a 17% better chance of anatomical improvement in prolapse stage [2]. The prevention leg: in the postpartum meta-analysis of 65 studies and 21,334 women, pelvic-floor muscle training cut the odds of prolapse by 56% (OR 0.44, 95% CI 0.21–0.91) alongside its 37% cut in urinary incontinence [3] — the number the pregnancy and postpartum doors already quote. And the device column stands beside, not instead: PESSRI randomized 134 women to three months each of ring-with-support and Gellhorn pessaries — both produced statistically and clinically significant symptom improvement, with no clinically meaningful difference between them [11]. Clinical practice runs these together — the pessary holds anatomy during the day while the floor trains underneath it, and training with a pessary in place is the standard pattern, not an exception [4][11]. Surgery remains the late column — for symptoms that defeat conservative care, at an incidence that peaks in the sixties [4] — and the reader who reaches that consult arrives stronger for having trained the floor first [1][2][3].

The program in gym terms: what trains, what ramps, what stops

Trains always: the whole library, plus one new muscle group. Whole-body progressive strength two-to-three times a week on the ordinary floor (the machines-vs-free-weights question answers to preference and tolerance here, not to the stage number) — and the pelvic floor trained deliberately: individualized, progressive, cue-based work in the POPPY shape [1], which is a training dose, not a pamphlet [2]. The floor trains like any other muscle — quality contractions, progressive hold-load, integrated into the lifts it supports — and it stacks with the incontinence benefit door's program rather than replacing it [3].

Ramps in-session dose like a beginner, whatever your lifting age says: the dose column prices session load, not training itself [7][10] — impact work (jumping, sprinting) and heavy hinge volume ramp on the ordinary ladder; exhale-on-effort replaces breath-holding under load [7]; positions that spike pressure get swapped for cousins that carry it (elevated split squats before flat bilateral hinges on heavy days, box steps before bounds).

Re-doses during flares, never cancels: a heavy evening after a big session is a ledger entry — next session smaller, impact out, symptom-free arcs only — the same architecture every rehab door in this library runs [7][10]. Heaviness that settles overnight is a dose signal; heaviness that no longer settles is the referral below.

Stops and refers: the red-flag column from the intro — retention, an unreducible bulge, bleeding, severe new pain — is same-day care; any new bulge sensation earns a clinician's exam with staging before it is programmed around [4]; and the post-hysterectomy reader takes her vigorous-dose question to the surgical team specifically, because that is the one subgroup the big cohort flagged [8].

Keeps one dated ledger: sessions, in-session heaviness (0–10), overnight settle yes/no, pessary dates if any — one timeline. It is how a dose meter gets read instead of feared [7][10].

The Brazil anchors: the 432-woman census

The pt-BR twin of this file exists for a Brazilian audience with one local anchor the English reader also benefits from knowing. The Brazilian census: 432 women seeking routine care, 52.3% carrying some stage of prolapse on exam — stage I 27.8%, stage II 23.1%, stage III 1.4% — with the risk-factor column led by vaginal delivery at OR 6.68 (95% CI 4.16–10.73), birth of an infant over 4 kg at OR 2.06, and menopause at OR 2.79 [12]. The authors' own conclusion belongs in the gym translation: eventual prolapse may be unavoidable in some women — the modifiable column is what the program touches [12]. Beside it, the São Paulo gestational back-pain census anchors the pelvic-family floor the pt-BR twin cross-links — the pregnancy, postpartum and incontinence doors already carry their Brazilian-relevant columns; this file adds the prolapse one.

So what do you actually do? The practical file

Six rules, every one sourced from the columns above:

  1. Get the exam, then read the census correctly. A stage number without symptoms describes the median parous pelvis — stage I or II in 91% of routine-care exams [6]; symptoms, not stage, are what gets treated [1][4].
  2. Retire the lifting-caused-it story. The biggest cohort (47,674 women, objectively measured, 8 years) found no association between moderate-to-vigorous activity and incident prolapse [8]; lifters read like matched controls [9]; parity and age are the risk column [4][12].
  3. Train the floor like the treatment it is. POPPY's winning program was individualized, supervised, progressive — symptom scores down 1.52 points at a year [1], anatomical stage 17% more likely to improve [2], postpartum odds cut 56% [3]. This is a dose, not a pamphlet.
  4. Manage the in-session dose meter. Symptoms track session load — OR 1.03 per weekly running kilometer [10], transient descent after single strenuous sessions [7] — so ramp impact and heavy hinges on a ladder, exhale on effort, and swap pressure-spiking positions for cousins.
  5. Price the device column honestly. Pessaries significantly improve symptoms, ring and Gellhorn equivalently [11]; training with one in place is the standard pattern — the pessary holds anatomy while the floor trains [1][11].
  6. Take the flags seriously and the calendar to the right door. Retention, unreducible bulge, bleeding, severe pain — same-day care [4]; postpartum readers take the giving-birth calendar first; post-hysterectomy readers take the vigorous-dose question to the surgical team — the one subgroup the big cohort flagged [8].

How RightRep fits into this

The prolapse file is, at its core, a dose-versus-symptom question — how much session load, shaped how, at what symptom response — and neither side of that ledger is answerable from memory:

  • The dose made measurable. The runner census priced symptoms per weekly kilometer [10]; logged volume, load and impact make the in-session dose a number instead of a feeling.
  • The floor program tracked. The treatment that works is progressive and individualized [1][2] — a training program, which means it responds to logging like every other muscle group's program.
  • The ramp governed. Impact and hinge volume grow on a ladder [7][10]; camera-scored reps hold the form standard while the load climbs.
  • The dated ledger, built in. Sessions, in-session heaviness, overnight settle — one timeline is the artifact that separates a dose signal from a progression and makes the next consult concrete [4][10].

The bottom line

  • The census: symptomatic prolapse 3–6% of women, up to 50% some degree on exam [4], half of parous women by the Cochrane's count [2]; Swift's curve — stage 0 6.4%, I 43.3%, II 47.7%, III 2.6% [6]; surgery twice as common as continence surgery, 6–18% lifetime, peaking in the sixties [4]; US forecast 3.3→4.9 million by 2050 [5].
  • The fear column: UK Biobank — 47,674 women, 8 years, objectively measured — no association between moderate/vigorous activity and incident prolapse [8]; CrossFit vs matched non-lifters 38.9% vs 44.4% with identical floor strength [9]; athletes 0–23% symptomatic, parity the only consistent correlate [7].
  • The dose column: runners — 23% symptomatic in-session, OR 1.03 per weekly km, additional activity OR 1.53, cesarean OR 0.42 [10]; transient post-session descent [7]; post-hysterectomy vigorous activity the one flagged subgroup (+53% per 15 min/day) [8].
  • The treatment column: POPPY — 447 randomized, symptom score −3.77 vs −2.09, adjusted difference 1.52 (0.46–2.59) at 12 months [1]; Cochrane — every symptom trial favored training, +17% improvement-in-stage odds [2]; postpartum prevention OR 0.44 [3].
  • The device column: PESSRI — 134 women, ring and Gellhorn both significantly improved symptoms, clinically equivalent [11].
  • The risk column: vaginal delivery OR 6.68, birth over 4 kg OR 2.06, menopause OR 2.79 — Brazil's 432-woman census at 52.3% on exam [12].
  • The Brazil anchor: the 432-woman routine-care census [12], cross-linked into the pt-BR twin.

Get the exam, read the census correctly, train the floor like a muscle, ramp the in-session dose like a beginner — and let the camera count the reps at rightrep.app.

This post was written by the RightRep AI Assistant — the same AI that counts and scores your reps at rightrep.app.

Sources

  1. Hagen S, Stark D, Glazener C, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. The Lancet, 2014;383(9919):796–806. pubmed.ncbi.nlm.nih.gov
  2. Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews, 2011;(12):CD003882. pubmed.ncbi.nlm.nih.gov
  3. Beamish NF, Davenport MH, Ali MU, et al. Impact of postpartum exercise on pelvic floor disorders and diastasis recti abdominis: a systematic review and meta-analysis. British Journal of Sports Medicine, 2025;59(8):562–575. pubmed.ncbi.nlm.nih.gov
  4. Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. International Urogynecology Journal, 2013;24(11):1783–1790. pubmed.ncbi.nlm.nih.gov
  5. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstetrics & Gynecology, 2009;114(6):1278–1283. pubmed.ncbi.nlm.nih.gov
  6. Swift SE. The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. American Journal of Obstetrics and Gynecology, 2000;183(2):277–285. pubmed.ncbi.nlm.nih.gov
  7. Bø K, et al. Strenuous physical activity, exercise, and pelvic organ prolapse: a narrative scoping review. International Urogynecology Journal, 2023;34(6):1153–1164. pubmed.ncbi.nlm.nih.gov
  8. Si K, Cao Z, Liu Q, et al. Accelerometer-measured physical activity, sedentary behavior, and risk of incident pelvic organ prolapse: a prospective cohort study. International Journal of Behavioral Nutrition and Physical Activity, 2024;21(1):12. pubmed.ncbi.nlm.nih.gov
  9. Arbieto ERM, Fukuda FS, Da Roza T, da Luz SCT. Pelvic Organ Prolapse Among Female CrossFitters and Non-CrossFitters: A Cross-Sectional Study. Sports Health, 2025. pubmed.ncbi.nlm.nih.gov
  10. Resende APM, de Oliveira WS, Dos Reis ACM, et al. Pelvic Organ Prolapse Symptoms in Female Runners: A Cross Sectional Study. International Urogynecology Journal, 2026;37(6):1773–1779. pubmed.ncbi.nlm.nih.gov
  11. Cundiff GW, Amundsen CL, Bent AE, et al. The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. American Journal of Obstetrics and Gynecology, 2007;196(4):405.e1–8. pubmed.ncbi.nlm.nih.gov
  12. Horst W, do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. International Urogynecology Journal, 2017;28(8):1165–1170. pubmed.ncbi.nlm.nih.gov